Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CO2 Fixation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CO2 fixation method for 4 5 dimethyl 1 3 dioxole 2 ketone offers safer greener pharmaceutical intermediate manufacturing with high purity and scalability.
Novel CuI catalytic method for 2-oxazolidinone intermediates. Reduces energy costs and enables scalable pharmaceutical manufacturing under ambient conditions.
Patent CN111454222A details a metal-free, one-step synthesis of quinazoline diones using CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN109651202A enables safe carbamate synthesis using CO2. Reduces toxicity risks and simplifies supply chain for pharmaceutical intermediates.
Patent CN111454222B reveals a metal-free CO2 fixation route for quinazolinediones. This method offers high yields, mild conditions, and significant cost reduction potential.